These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38279939)

  • 1. Success of the US Veterans Health Administration's Hepatitis C Virus Care Continuum in the Direct-acting Antiviral Era.
    Varley CD; Lowy E; Cartwright EJ; Morgan TR; Ross DB; Rozenberg-Ben-Dror K; Beste LA; Maier MM
    Clin Infect Dis; 2024 Jun; 78(6):1571-1579. PubMed ID: 38279939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative treatment effectiveness of direct acting antiviral regimens for hepatitis C: Data from the Veterans administration.
    Fox DS; McGinnis JJ; Tonnu-Mihara IQ; McCombs JS
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1136-1142. PubMed ID: 27869323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cascade of Care for Hepatitis C Virus Infection Within the US Veterans Health Administration.
    Maier MM; Ross DB; Chartier M; Belperio PS; Backus LI
    Am J Public Health; 2016 Feb; 106(2):353-8. PubMed ID: 26562129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained virologic response with 6 weeks or less of direct-acting antiviral therapy for chronic hepatitis C: Experience at a veterans affairs healthcare system.
    Joshi P; Atherton A
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2173-2178. PubMed ID: 31062412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C Care in the Department of Veterans Affairs: Building a Foundation for Success.
    Belperio PS; Chartier M; Gonzalez RI; Park AM; Ross DB; Morgan TR; Backus LI
    Infect Dis Clin North Am; 2018 Jun; 32(2):281-292. PubMed ID: 29778256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world experiences with direct-acting antiviral agents for chronic hepatitis C treatment.
    Daniel KE; Saeian K; Rizvi S
    J Viral Hepat; 2020 Feb; 27(2):195-204. PubMed ID: 31602715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating Hepatitis C in Individuals With Previous Incarceration: The Veterans Health Administration, 2012-2019.
    Hawks L; Wang EA; Butt AA; Crystal S; Keith McInnes D; Re VL; Cartwright EJ; Puglisi LB; Haque LYK; Lim JK; Justice AC; McGinnis KA
    Am J Public Health; 2023 Feb; 113(2):162-165. PubMed ID: 36480765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C-Related Hepatocellular Carcinoma Incidence in the Veterans Health Administration After Introduction of Direct-Acting Antivirals.
    Beste LA; Green P; Berry K; Belperio P; Ioannou GN
    JAMA; 2020 Sep; 324(10):1003-1005. PubMed ID: 32897335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detectable Viremia at the End of Treatment With Direct-Acting Antivirals Can Be Associated With Subsequent Clinical Cure in Patients With Chronic Hepatitis C: A Case Series.
    Childs-Kean LM; Hong J
    Gastroenterology; 2017 Oct; 153(4):1165-1166. PubMed ID: 28881195
    [No Abstract]   [Full Text] [Related]  

  • 10. Initial uptake, time to treatment, and real-world effectiveness of all-oral direct-acting antivirals for hepatitis C virus infection in the United States: A retrospective cohort analysis.
    Kwo PY; Puenpatom A; Zhang Z; Hui SL; Kelley AA; Muschi D
    PLoS One; 2019; 14(8):e0218759. PubMed ID: 31437170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies.
    Sarrazin C; Isakov V; Svarovskaia ES; Hedskog C; Martin R; Chodavarapu K; Brainard DM; Miller MD; Mo H; Molina JM; Sulkowski MS
    Clin Infect Dis; 2017 Jan; 64(1):44-52. PubMed ID: 27737953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated with Sustained Virologic Response to Hepatitis C Treatment in a Homeless-Experienced Cohort in Boston, 2014-2020.
    Beiser ME; Shaw LC; Wilson GA; Muse KO; Shores SK; Baggett TP
    J Gen Intern Med; 2023 Mar; 38(4):865-872. PubMed ID: 36127534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of a Sustained Virologic Response to Hepatitis C Virus Treatment on Liver Stiffness in the Puerto Rico Veterans Attending Liver Clinics in the Veterans Affairs Caribbean Healthcare System.
    Rabell-Bernal A; López-Valle R; Morales-Santiago A; Toro DH
    P R Health Sci J; 2022 Sep; 41(3):123-127. PubMed ID: 36018739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.
    Chan K; Lai MN; Groessl EJ; Hanchate AD; Wong JB; Clark JA; Asch SM; Gifford AL; Ho SB
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1503-10. PubMed ID: 23707354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus care cascade in persons experiencing homelessness in the United States in the era of direct-acting antiviral agents: A scoping review.
    Del Rosario A; Eldredge JD; Doorley S; Mishra SI; Kesler D; Page K
    J Viral Hepat; 2021 Nov; 28(11):1506-1514. PubMed ID: 34314081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. User experience of a hepatitis c population management dashboard in the Department of Veterans Affairs.
    Yakovchenko V; Jacob DA; Rogal SS; Morgan TR; Rozenberg-Ben-Dror K
    PLoS One; 2023; 18(5):e0285044. PubMed ID: 37130107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of occult hepatitis C virus infection in patients who achieved sustained virologic response to direct-acting antiviral agents.
    Yousif MM; Elsadek Fakhr A; Morad EA; Kelani H; Hamed EF; Elsadek HM; Zahran MH; Fahmy Afify A; Ismail WA; Elagrody AI; Ibrahim NF; Amer FA; Zaki AM; Sadek AMEM; Shendi AM; Emad G; Farrag HA
    Infez Med; 2018 Sep; 26(3):237-243. PubMed ID: 30246766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained Virologic Response of Patients Hospitalized Compared With Those Not Hospitalized During Treatment for Hepatitis C Virus With Direct-Acting Antivirals.
    Gentene AJ; Bell AM; Pence A; Thomas K; Jakubecz C; Stacy E; Woolf B; Guido MR; Mueller EW; Sherman KE
    Ann Pharmacother; 2021 May; 55(5):565-574. PubMed ID: 33016095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders.
    Fuchs M; Monto A; Bräu N; Charafeddine M; Schmidt W; Kozal M; Naggie S; Cheung R; Schnell G; Yu Y; Richards K; Mullally V; Cohen DE; Toro D
    J Med Virol; 2020 Dec; 92(12):3459-3464. PubMed ID: 31829433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world effectiveness of elbasvir/grazoprevir In HCV-infected patients in the US veterans affairs healthcare system.
    Kramer JR; Puenpatom A; Erickson KF; Cao Y; Smith D; El-Serag HB; Kanwal F
    J Viral Hepat; 2018 Nov; 25(11):1270-1279. PubMed ID: 29851265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.